Compare INVH & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INVH | SPRC |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | Israel |
| Employees | N/A | 2 |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.5B | 4.8M |
| IPO Year | 2017 | N/A |
| Metric | INVH | SPRC |
|---|---|---|
| Price | $27.45 | $1.48 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $34.90 | N/A |
| AVG Volume (30 Days) | ★ 5.3M | 1.3M |
| Earning Date | 10-29-2025 | 03-23-2026 |
| Dividend Yield | ★ 4.37% | N/A |
| EPS Growth | ★ 32.35 | N/A |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $2,689,621,000.00 | $1,306,000.00 |
| Revenue This Year | $5.69 | N/A |
| Revenue Next Year | $3.21 | N/A |
| P/E Ratio | $28.89 | ★ N/A |
| Revenue Growth | 5.29 | ★ 187.98 |
| 52 Week Low | $26.02 | $1.30 |
| 52 Week High | $35.80 | $37.59 |
| Indicator | INVH | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 50.57 | 34.70 |
| Support Level | $26.72 | $1.35 |
| Resistance Level | $27.43 | $1.71 |
| Average True Range (ATR) | 0.47 | 0.17 |
| MACD | 0.10 | 0.02 |
| Stochastic Oscillator | 93.29 | 21.88 |
Invitation Homes owns a portfolio of over 85,000 single-family rental homes. The company focuses on owning homes in the starter and move-up segments of the housing market with an average sale price around $350,000 and generally less than 1,800 square feet. The portfolio is spread across 17 target markets that feature high employment and household formation growth with over 70% of the portfolio in the Western US and Florida; 15 of the 17 markets featuring average rents lower than homeownership costs.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.